Influenza Clinical Trials

Influenza clinical trials are research studies that test vaccines, prevention strategies, and other approaches aimed at reducing the impact of the flu each season. Researchers use these studies to understand how the virus changes from year to year, and to see how well different prevention methods work across different age groups and risk levels.

Flu clinical trials matter because influenza strains shift constantly, and last year's approach isn't always effective against this year's virus. By testing vaccine formulations and other prevention strategies, researchers can help keep public health responses up to date and better protect people who are most vulnerable to severe illness, like older adults, young children, and those with chronic conditions.

Influenza research spans a few distinct types of trials, each focused on a different way to understand the virus and get ahead of it each season.

Vaccine trials

Flu vaccine clinical trials make up the majority of influenza research, testing formulations and dosing across different age groups and risk levels to see how well they protect against seasonal and emerging flu strains.

Participants typically include healthy adults, older adults, children, and other groups often prioritized for vaccination each season. Studies usually compare a formulation against an existing vaccine or a placebo, tracking how well the immune system responds and how well it protects against illness.

Wondering how long vaccine research takes? Learn more:

How Long Are Clinical Trials for Vaccines?

Antiviral and antibody trials

These trials study medications and antibody-based approaches for people who've already been exposed to the flu or are at high risk of severe illness, looking at how well they ease symptoms, shorten recovery time, or help prevent complications.

Participants often include people recently diagnosed with the flu, those in high-risk groups like older adults or people with chronic conditions, and sometimes healthy volunteers used to study how the antiviral or antibody behaves in the body.

Human challenge studies

Human challenge studies are a distinctive part of influenza research, where healthy volunteers are deliberately exposed to the flu virus under closely monitored, controlled conditions. This approach lets researchers study how the virus behaves and how well a vaccine or antiviral works much faster than waiting for natural flu season exposure.

Participants are typically healthy adults who go through extensive screening beforehand and stay under close medical supervision throughout the study, since safety monitoring is a central part of this type of research.

Not exactly. Trials that test how well a vaccine or antiviral actually works against a real flu infection typically run during flu season in the U.S., which usually spans from around October through May, since researchers need participants to be naturally exposed to the virus to see meaningful results.

Other types of influenza trials don't depend on flu season at all. Early safety studies and human challenge studies, for example, don't rely on natural exposure, since human challenge studies deliberately expose volunteers to the virus under closely controlled conditions, they can be scheduled at almost any time of year, even outside the typical flu season.

Eligibility for participating in an influenza clinical trial varies depending on the specific study, but generally, both healthy volunteers and people at higher risk of severe flu may qualify, depending on what's being tested. Vaccine trials often look for healthy participants across different age groups, while antiviral and antibody trials may focus on people who've recently been diagnosed with the flu or are at high risk of complications.

For most trials, eligibility criteria often include factors like age, current health status, vaccination history, and the time of year, since many influenza trials run during flu season. Some studies, like human challenge trials, require extensive health screening since participants are deliberately exposed to the virus under close supervision.

What to expect in an influenza clinical trial

When participating in an influenza clinical trial, participants can expect to go through a thorough screening process to make sure they meet the study's specific inclusion and exclusion criteria. Following this, a detailed informed consent will be provided, explaining the study's purpose, procedures, risks, and benefits.

During the trial, participants may receive a vaccine formulation, an antibody, or a placebo, along with regular monitoring through check-ins, symptom tracking, and lab tests to see how their body responds over the course of the study.

Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.

Clinical Trial Benefits, Risks & Safety Considerations

Enrolling in an influenza clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:

1. Identify Your Trial: Use our intuitive search bar or filter options to locate influenza clinical trials currently enrolling. This first step simplifies the process of finding relevant research studies tailored to you.
2. Select Your Preferred Location: To find flu clinical trials near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
3. Explore Study Details: For in-depth information about each study, simply click the "Learn More" button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
4. Complete the Health Profile: After clicking on the "Get started" button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
5. Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.